Infantile Hemangiomas: Daily Timolol Maleate Slows GrowthInfantile Hemangiomas: Daily Timolol Maleate Slows Growth

The gel formulation of a medicine approved in 1978 to treat glaucoma slows the growth of potentially disfiguring infantile hemangiomas with few of the adverse effects that limit other treatments. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pediatrics News Source Type: news